Abstract
Introduction: Treatment for Human Immunodeficiency Virus (HIV) infections using antiretroviral (ARV) resulting in varying stage response in the oral cavity. Some studies showed good responses but can also lead to Immune Reconstitution Inflammatory Syndrome (IRIS). IRIS is widely known as a complication of ARV therapy. Oral lesions in HIV / AIDS patients that emerge after taking ARV therapy can be categorized as IRIS cases. This systemic review aims to observe oral manifestations associated with IRIS. Review: Systematic review is carried out by the PRISMA method. The inclusion criteria are clinical trial articles collected from electronic searches, including full text through the PubMed portal, Research Gate, and Google Scholar using keywords: HIV / AIDS, IRIS, and oral manifestations which were published from 2011 to December 2019. A total of 6 articles were identified. The results showed that oral lesions in HIV/ AIDS related to IRIS are Kaposi Sarcoma 29.2%, OHL 16.9%, oral candidiasis 11.5%, and RAS 5.6%. The incidence of IRIS was around 10-27% in HIV / AIDS patients who have started ARV therapy. The incidence of IRIS is higher in prevalence in patients starting ARV therapy with low CD4 counts. Conclusion: Oral manifestations associated with IRIS in most HIV /AIDS patients are Kaposi's Sarcoma, OHL, Oral candidiasis, and SAR
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: B-Dent: Jurnal Kedokteran Gigi Universitas Baiturrahmah
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
